The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The FluMist vaccine can now be self-administered after the FDA approved its use to treat the influenza disease.

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...

The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...

AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...

美国FDA批准了阿斯利康旗下的无针鼻腔喷雾剂FluMist，用于预防2至49岁人群中由A型和B型流感病毒引起的流感疾病。FluMist成为首款可供符合条件的患者自行接种或由照护者接种的流感疫苗。

There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...

英国剑桥 - ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

Phillip Smith, Pharmacist with Access Pharmacy, FluMist has been used by Local pharmacies for several years ... But, two to ...

Sept. 23, 2024 – The FDA on Friday approved FluMist, a nasal spray flu vaccine that you or a caregiver can now give at home – no health care provider needed. It’s the first flu vaccine of its kind, ...

智通财经APP获悉，美国FDA批准了阿斯利康（AstraZeneca，AZN.US）旗下的无针鼻腔喷雾剂FluMist，用于预防2至49岁人群中由A型和B型流感病毒引起的流感疾病。FluMist成为首款可供符合条件的患者自行接种或由照护者接种的流感疫苗。